Corning
xeno-free recombinant-vitronectin surfaces plus a 2024–2026 patent portfolio (WO2026111865A1 cell harvesting, WO2026111890A1 cell filtering) anchoring an integrated fixed-bed offering.
- Country
- United States
- Ticker
- NYSE:GLW
Commercial
Synthemax
Dissolvable MCs
Coverage
| CN | EU | US | |
|---|---|---|---|
| consumables | ✓ | ✓ | ✓ |
| fill-finish-packaging | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Microcarriers for adherent cell cultures | consumables | Low | → |
| mRNA / LNP manufacturing equipment | fill-finish-packaging | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.